These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2113808)

  • 61. Invitro comparative evaluation of aminoglycosides at a cancer centre.
    Biswas SK; Kelkar RS
    Indian J Cancer; 2002; 39(4):135-8. PubMed ID: 12928571
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Susceptibility of gram-negative bacilli to aminoglycosides].
    Willke A; Tural D
    Mikrobiyol Bul; 1987 Apr; 21(2):98-102. PubMed ID: 3328818
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Preclinical comparative evaluation of aminoglycosides.
    Abbate GF; Alagia I; Giaquinto E; Giordano B; Leonessa V; Altucci P
    Chemioterapia; 1984 Dec; 3(6):378-84. PubMed ID: 6529780
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic.
    Miller GH; Arcieri G; Weinstein MJ; Waitz JA
    Antimicrob Agents Chemother; 1976 Nov; 10(5):827-36. PubMed ID: 1008541
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals.
    Schmitz FJ; Fluit AC; Gondolf M; Beyrau R; Lindenlauf E; Verhoef J; Heinz HP; Jones ME
    J Antimicrob Chemother; 1999 Feb; 43(2):253-9. PubMed ID: 11252331
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Susceptibility to beta-lactam antibiotics in septicemia isolates from twenty-nine European laboratories. European Study Group on Antibiotic Resistance.
    Eur J Clin Microbiol; 1987 Oct; 6(5):515-20. PubMed ID: 3436313
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Development of resistance to aminoglycosides among coagulase-negative staphylococci and enterobacteriaceae in a neonatal intensive care unit.
    Krediet TG; Fleer A; Gerards LJ
    J Hosp Infect; 1993 May; 24(1):39-46. PubMed ID: 8101201
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Comparative study of the effect of sisomicin and other aminoglycosides on the causative agents of surgical infection].
    Navashin PS
    Antibiotiki; 1982 Dec; 27(12):26-9. PubMed ID: 6819812
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Endemic aminoglycoside resistance in gram-negative bacilli: epidemiology and mechanisms.
    Weinstein RA; Nathan C; Gruensfelder R; Kabins SA
    J Infect Dis; 1980 Mar; 141(3):338-45. PubMed ID: 6767795
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Postantibiotic effect of aminoglycosides on staphylococci.
    Isaksson B; Maller R; Nilsson LE; Nilsson M
    J Antimicrob Chemother; 1993 Aug; 32(2):215-22. PubMed ID: 8226423
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In vitro studies with Win 42122-2: comparison with gentamicin, netilmicin, and amikacin.
    Sanders CC; Sanders WE
    Antimicrob Agents Chemother; 1981 Aug; 20(2):247-51. PubMed ID: 7283421
    [TBL] [Abstract][Full Text] [Related]  

  • 72. 3-0-demethyl fortimicin A: in vitro activity and interpretive zone standards for disk diffusion susceptibility tests.
    Barry AL; Jones RN; Thornsberry C; Gavan TL; Gerlach EH; Sommer HM
    Eur J Clin Microbiol; 1984 Dec; 3(6):531-7. PubMed ID: 6441709
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [The antimicrobial activity of amikacin in comparison with three other aminoglycoside-antibiotics (author's transl)].
    Jotzoff M
    Med Klin; 1978 Jun; 73(24):914-7. PubMed ID: 661734
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In vitro evaluation of N-formimidoyl thienamycin (MK0787) combined with amikacin against gram-negative bacilli and Staphylococcus aureus.
    Díez Enciso M; Mateos Lindemann M; Gutiérrez Altés A
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1064-6. PubMed ID: 6818899
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Selection of subpopulations resistnat to amikacin and netilmicin of gentamicin-resistant clinical strains of Staphylococcus aureus and Staphylococcus epidermidis.
    Torres García M; Tejedor Junco MT; González Martín M; González Lama Z
    Zentralbl Bakteriol; 1996 Jun; 284(1):58-66. PubMed ID: 8837369
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Resistance surveillance programs and the incidence of gram-negative bacillary resistance to amikacin from 1967 to 1985.
    Gerding DN; Larson TA
    Am J Med; 1986 Jun; 80(6B):22-8. PubMed ID: 3089003
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antimicrobial activity of cefotiam combinations against Enterobacteriaceae moderately susceptible or resistant to this new cephalosporin.
    Husson MO; Izard D; Leclerc H
    Drugs Exp Clin Res; 1986; 12(4):325-7. PubMed ID: 3459642
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
    Drugeon HB; Courtieu AL
    Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Aminoglycoside resistance among Danish blood culture isolates of coagulase-negative staphylococci.
    Busch-Sørensen C; Frimodt-Møller N; Miller GH; Espersen F
    APMIS; 1996 Dec; 104(12):873-80. PubMed ID: 9048865
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antimicrobial susceptibility of gentamicin-resistant Pseudomonas aeruginosa.
    Yu PK; Washington JA
    Mayo Clin Proc; 1977 Dec; 52(12):802-5. PubMed ID: 413013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.